No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs34866169 |
chr3:143068463-143068464 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs74561965 |
chr3:143068486-143068487 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs185162274 |
chr3:143068491-143068492 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs577417921 |
chr3:143068494-143068495 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs538539988 |
chr3:143068516-143068517 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs112788003 |
chr3:143068535-143068536 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs574999303 |
chr3:143068538-143068539 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs542024459 |
chr3:143068542-143068543 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs544334988 |
chr3:143068545-143068546 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs560249567 |
chr3:143068595-143068596 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs193238987 |
chr3:143068599-143068600 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs545842454 |
chr3:143068606-143068607 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs564133228 |
chr3:143068669-143068670 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs531557429 |
chr3:143068709-143068710 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs550870765 |
chr3:143068720-143068721 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs142938427 |
chr3:143068728-143068729 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs114141073 |
chr3:143068749-143068750 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs145135496 |
chr3:143068758-143068759 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs566617156 |
chr3:143068782-143068783 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs374274835 |
chr3:143068783-143068784 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs552260891 |
chr3:143068785-143068786 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs570429990 |
chr3:143068795-143068796 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs111828520 |
chr3:143068818-143068819 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs530928414 |
chr3:143068904-143068905 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs560835239 |
chr3:143068916-143068917 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs138966600 |
chr3:143068925-143068926 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs568645822 |
chr3:143068938-143068939 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs111544803 |
chr3:143068958-143068959 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs542681502 |
chr3:143068997-143068998 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs553945225 |
chr3:143069052-143069053 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs561350468 |
chr3:143069066-143069067 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs572249346 |
chr3:143069081-143069082 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs72992112 |
chr3:143069097-143069098 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
34 |
rs542021604 |
chr3:143069142-143069143 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs557941192 |
chr3:143069158-143069159 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs576397667 |
chr3:143069159-143069160 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs543435472 |
chr3:143069216-143069217 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs562828080 |
chr3:143069218-143069219 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs547121795 |
chr3:143069224-143069225 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs75488667 |
chr3:143069269-143069270 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs542085137 |
chr3:143069299-143069300 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs560398630 |
chr3:143069303-143069304 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs6775025 |
chr3:143069304-143069305 |
Enhancers Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
44 |
rs551253855 |
chr3:143069351-143069352 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs570418879 |
chr3:143069390-143069391 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs369406154 |
chr3:143069419-143069420 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs184468215 |
chr3:143069429-143069430 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs188277573 |
chr3:143069448-143069449 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
49 |
rs142207071 |
chr3:143069473-143069474 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs535740792 |
chr3:143069490-143069491 |
Enhancers Weak transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|